ACCRF Year-End Letter
A blend of annual accomplishments, patient education resources and clinical [...]
Update for Researchers
A review of recent developments, including The Landscape of ACC [...]
More on “Quiet” Genomes
Yet another seminal study of ACC genomics reveals "quiet" genomes [...]
Genomic Findings, Clinical Trials & Patient Activities
The past few months have seen a flurry of significant [...]
ACCRF Year End Letter
Highlights from a remarkable year include a third Dovitinib clinical [...]
3rd Workshop on Salivary Gland Tumors
The re-invigoration of the field of salivary gland tumor research [...]
Dr. Adel El-Naggar
Dr. Adel El-Naggar's expertise and collaborative spirit have spurred numerous advances in ACC biobanking, genomics and target identification.
ACCRF Scientific Advisory Board
ACCRF’s Scientific Advisory Board (SAB) has been fundamental to all the foundation’s activities, laying the groundwork for the remarkable research progress of the past several years.
Dan Dubé
Dan Dubé is remembered as the vibrant, committed and empathetic champion of the ACC patient community that, more than anyone, he helped build.
Dovitinib Study Opens at the University of Virginia
The University of Virginia has begun screening ACC patients with [...]
